Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

PUBM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that PubMatic, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

(NASDAQ:PUBM) SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning PubMatic business and prospects, resulting in its stock trading at inflated prices.

Will the legal proceedings trigger any changes in institutional ownership or trigger stop‑loss orders among large shareholders? What are the potential financial liabilities or settlement costs associated with the lawsuit and how could they impact earnings guidance? How might the pending class action lawsuit affect PubMatic's short‑term stock volatility and trading volume?
Symbol: PUBM
Lawsuits
8 days ago
Read more businesswire

equipifi® Joins the Jack Henry™ Fintech Integration Network and Expands Access to Bank BNPL

(NASDAQ:JKHY) - FIN enables equipifi to expand flexible financing capabilities to hundreds more financial institutions by integrating with SilverLake System®- SCOTTSDALE, Ariz., Sept. 4, 2025 /PRNe...

How does this integration position Jack Henry against its fintech competitors and could it lead to a re‑rating of its valuation multiples? What is the expected timeline for roll‑out of the BNPL solution across the network's member banks and its projected impact on loan portfolio metrics? How will the partnership with equipifi affect Jack Henry's short‑term revenue and earnings forecasts?
Symbol: JKHY
Partnership
8 days ago
Read more prnewswire

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)

(NASDAQ:MNMD) NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidat...

How does MM120’s efficacy and dose‑response profile compare to existing GAD treatments and other pipeline competitors? What are the projected regulatory milestones and potential timeline for FDA approval of MM120 following this trial? How will the Phase 2b results affect MindMed’s near‑term stock price and trading volume?
Symbol: MNMD
Clinical trials
8 days ago
Read more businesswire

Investments in smart grid technology keep lights on for DTE customers, preventing more than 16,000 outages so far this year

(NYSE:DTE) DETROIT, Sept. 04, 2025 (GLOBE NEWSWIRE) -- DTE Energy (NYSE:DTE) today announced a milestone in its work to improve electric reliability for customers. So far this year, DTE’s smart g...

Could the outage‑reduction targets and associated technology deployments influence regulatory filings or rate case outcomes for DTE? What is the timeline and capital allocation for the remaining portion of the $10 billion grid modernization plan, and how does it compare to peers' investment programs? How will the reported reduction in outages and the smart grid rollout affect DTE's earnings guidance and valuation multiples?
Symbol: DTE
Energy
8 days ago
Read more globenewswire

DeFi Development Corp. Acquires 196,141 SOL, Surpasses 2 Million in Total SOL Treasury Holdings

(NASDAQ:DFDV) BOCA RATON, FL, Sept. 04, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and co...

How does DFDV's SOL accumulation strategy compare to other crypto‑focused public companies and what are the potential risks if SOL's price declines? What is the financing source for this acquisition and does it dilute existing shareholders? How will the increased SOL exposure affect DFDV's stock valuation and volatility?
Symbol: DFDV
Acquisitions
8 days ago
Read more globenewswire